“…An abnormal accumulation of lipofuscin is a major risk factor implicated in different forms of macular degeneration (Delori et al, 1995a; Marmorstein et al, 2002; Gerth et al, 2007; Biarnes et al, 2015), and also the most notable and consistent pathological finding in BEST1 -linked maculopathies, serving as an indirect biomarker of metabolic activity between the photoreceptor outer segment (POS) turnover and RPE phagocytosis (Bakall et al, 2007; Piñeiro-Gallego et al, 2011; Lei et al, 2013; Singh et al, 2013a). Recent advances with noninvasive retinal imaging modalities have enabled detailed mapping and quantification of fundus autofluorescence (FAF) in vivo , and its correlation with increased levels of lipofuscin components in the aged and diseased retinae (Delori et al, 1995a, 1995b; Brunk and Terman, 2002; Boon et al, 2008; Duncker et al, 2014); however, the polymorphous nature of lipofuscin material and consequences of its buildup in the retina are still controversial.…”